Abstract:Ethnopharmacological relevance: Artemisia mongolica is well known for its use in folk medicine, it is commonly used to alleviate a variety of diseases associated with inflammation, such as laryngitis, tonsillitis, headaches and hepatitis in northwest China. However, its anti-inflammatory mechanism is still unknown. Aim of the study: The most potential anti-inflammatory part (AMPA) was identified by screening individual parts of A. Mongolica. After the network pharmacological analysis, the anti-inflammation effects and molecular mechanisms of AMPA were evaluated in RAW264.7 cells induced by LPS. Materials and methods: AMPA was chosen as the most anti-inflammatory of the A. Mongolica, as measured by the effect of each part of the A. Mongolica on NO and COX-2. The chemical composition of AMPA was identified using HPLC-Q-TOF-MS/MS, and targets of bioactive chemicals and targets related to inflammation were found using open-source databases. The "Compound-targets" network and PPI network were established by combining compounds and overlapped targets, and targets in the PPI networks were analyzed by GO and KEGG enrichment. The RAW26.7 cells induced by LPS were used as a model of inflammation examination. MTT assay was performed to assess the cytotoxicity of AMPA on LPS-induced RAW264.7 cells. The level of NO was measured by the Griess method while the inflammatory factors were detected by ELISA. The protein expression levels of iNOS, COX-2, MAPK, NF-κB signaling pathway and AMPK/Nrf2-related proteins were determined by Western blot. The results of nuclear translocation of p65 and Nrf2 were analyzed by immunofluorescence assay. Results: A total of 18 compounds with potential bioactivity were identified, and after intersecting 640 compound-predicted targets and 1608 inflammation targets, the compounds and intersected targets were utilized to structure "compound-target" and PPI networks. Among AMPA, AM6, AM7, AM11, AM8 and AM1 compounds were essential in the "compound-targets" network, meanwhile, TNF, RELA, MAPK1, NOS2, PRKAG, and PTGS2 targets play important roles in the PPI network. The top 10 terms and pathways were obtained based on GO and KEGG. The cell experiments show that 50 μg/mL was the maximum concentration of AMPA without cytotoxicity in the LPS-induced RAW264.7 cell model. When compared with the LPS group, AMPA treatment not only effectively suppressed the generation of NO, TNF-α, IL-6, PGE2, IL-1β and MCP-1 in LPS-induced RAW264.7 cells, but also down-regulated the expression of COX-2, iNOS and the protein levels p-ERK, p-p38, p-IκB-α and p-p65, inhibited the nuclear translocation of p65. Furthermore, the expression levels of p-LKB1, p-AMPK, Nrf2 and HO-1 proteins were up-regulated and Nrf2 nuclear translocation was promoted. Conclusion: AMPA should be considered an anti-inflammatory agent for the results of network pharmacology and in vitro, which could inhibit the MAPK pathway and NF-κB pathway and activate the AMPK/Nrf2 pathway in LPS-stimulated RAW264.7 cells.

Ampelopsin Attenuates Lipopolysaccharide-Induced Inflammatory Response Through the Inhibition of the NF-κB and JAK2/STAT3 Signaling Pathways in Microglia.

Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways

Inhibitory effects of ampelopsin on translocation and secretion of HMGB1 in BV2 microglial cells induced by LPS

Ampelopsin Attenuates 6-Ohda-induced Neurotoxicity by Regulating GSK-3β/NRF2/ARE Signalling

Aspirin-triggered Lipoxin A 4 Attenuates LPS-induced Pro-Inflammatory Responses by Inhibiting Activation of NF-κB and MAPKs in BV-2 Microglial Cells

Dalesconols B Inhibits Lipopolysaccharide Induced Inflammation and Suppresses NF-κB and P38/jnk Activation in Microglial Cells

The Anti-inflammatory Effects of 4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic Acid in Lipopolysaccharide-Activated Primary Microglial Cells

Adrenomedullin 2 attenuates LPS-induced inflammation in microglia cells by receptor-mediated cAMP-PKA pathway

Anti-Neuroinflammatory Effect of Sophoraflavanone G from Sophora Alopecuroides in Lps-Activated Bv2 Microglia by Mapk, Jak/Stat and Nrf2/Ho-1 Signaling Pathways

Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF–κB and STAT3 signaling pathways

Anti-inflammatory effect and mechanism of active parts of Artemisia mongolica in LPS-induced Raw264.7 cells based on network pharmacology analysis

C16 Peptide and Angiopoietin-1 Protect Against LPS-induced BV-2 Microglial Cell Inflammation.

Asperosaponin VI Inhibits LPS-induced Inflammatory Response by Activating PPAR-γ Pathway in Primary Microglia

Lipoxin A4 Regulates Lipopolysaccharide-Induced BV2 Microglial Activation and Differentiation Via the Notch Signaling Pathway.

Luteolin Inhibits SH-SY5Y Cell Apoptosis Through Suppression of the Nuclear Transcription Factor-Κb, Mitogen-Activated Protein Kinase and Protein Kinase B Pathways in Lipopolysaccharide-Stimulated Cocultured BV2 Cells.

Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways

Alismol, a Sesquiterpenoid Isolated from Vladimiria souliei , Suppresses Proinflammatory Mediators in Lipopolysaccharide-Stimulated Microglia

Sinapic Acid Attenuates the Neuroinflammatory Response by Targeting AKT and MAPK in LPS-Activated Microglial Models

Amentoflavone Exerts Anti-Neuroinflammatory Effects by Inhibiting TLR4/MyD88/NF-κB and Activating Nrf2/HO-1 Pathway in Lipopolysaccharide-Induced BV2 Microglia

Evodiamine Inhibits Lipopolysaccharide (Lps)-Induced Inflammation in BV-2 Cells Via Regulating AKT/Nrf2-HO-1/NF-κB Signaling Axis.

Resveratrol Inhibits Inflammatory Responses Via The Mammalian Target Of Rapamycin Signaling Pathway In Cultured Lps-Stimulated Microglial Cells